MPAM
IMGN

Monarch Partners Asset Management’s Immunogen Inc IMGN Stock Holding History

Monarch Partners Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-674,845
Closed -$3.23M – 161
2022
Q3 		$3.23M Buy
+674,845
New +$3.56M 0.97% 30
2021
Q3 		– Sell
-228,125
Closed -$1.5M – 180
2021
Q2 		$1.5M Buy
228,125
+135,345
+146% +$944K 0.22% 132
2021
Q1 		$752K Sell
92,780
-13,385
-13% -$109K 0.11% 141
2020
Q4 		$685K Sell
106,165
-11,480
-10% -$67K 0.12% 156
2020
Q3 		$424K Buy
117,645
+37,920
+48% +$153K 0.1% 152
2020
Q2 		$367K Buy
+79,725
New +$339K 0.09% 154

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Monarch Partners Asset Management's IMGN Position: Q4 2022 in Review

Monarch Partners Asset Management sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 674,845 shares — an estimated $3.23M sold.

Monarch Partners Asset Management first reported a position in IMGN in Q2 2020 and held it in 6 quarters. The position peaked at $3.23M in Q3 2022. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Monarch Partners Asset Management reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Monarch Partners Asset Management sold 674,845 Immunogen Inc shares in Q4 2022, an estimated $3.23M.
  • Monarch Partners Asset Management first reported a position in Immunogen Inc in Q2 2020 and held it in 6 quarters.
  • Monarch Partners Asset Management's Immunogen Inc position peaked at $3.23M in Q3 2022.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.